International Journal of Travel Medicine and Global Health

International Journal of Travel Medicine and Global Health

Chronic Mountain Sickness (Cms) Misdiagnosed As High Altitude Cerebral Edema (Hace) At Extreme Altitude (6400 M/21000 Ft)

Document Type : Case Report

Author
Clinical Microbiology, Army College of Medical Sciences and Base Hospital, Delhi Cantt 110010, India
Abstract
Introduction: Chronic mountain sickness (CMS) represents a syndrome of secondary polycythemia along with thrombocytopenia, altered hemorheology, pulmonary and systemic hypertension, and congestive heart failure, occurring due to hypobaric hypoxia-anoxia-induced erythropoiesis reported in both native mountain residents and new climbers after prolonged stays at high and extreme altitudes.
Case Presentation: A healthy non-smoker non-drinker reported occipital headache, breathlessness, and insomnia after an uneventful stay of 70 days at 6400 m/21000 ft. His hemoglobin was 21 gm/dL. The patient was diagnosed as having a case of CMS with a Qinghai CMS score >6. Therapeutic phlebotomy was performed; 350 mL was drained on two occasions, reducing his hemoglobin to 14.6 gm/dL.
Conclusion: The altered presentation, difficult diagnosis, evacuation, and long-term management highlighted in this case occurring at 6400 m/21 000 ft in the Karakoram Himalayas represents the insidious nature of altitude sickness in acclimatized subjects.
Keywords

  1. León-Velarde F, Villafuerte FC, Richalet JF. Chronic mountain sickness and the heart. Prog Cardiovasc Dis. 2010 ;52(6):540-549. doi:10.1016/j.pcad.2010.02.012.
  2. Khan ID. Extreme Altitude Pulmonary Oedema in Acclimatized Soldiers. Med J Armed Forces India. 2012;68(4):339-345. doi:10.1016/j.mjafi.2012.04.018.
  3. Khan ID. Comorbid cerebral and pulmonary edema at 7010 m/23000 ft: an extreme altitude perspective. J Med. 2013;14(2):153-155. doi:10.3329/jom.v14i2.19668.
  4. Khan ID. Cerebral venous sinus thrombosis (CVST) masquerading as high altitude cerebral edema (HACE) at extreme altitude (6700 m/22000 ft). Int J Travel Med Glob Health. 2016;4(3):96-98. doi:10.21859/ijtmgh-040306.
  5. Khan ID, Sahni AK. Possession syndrome at high altitude (4575 m/15000 ft). Kathmandu Univ Med J (KUMJ). 2013;43(3):247-249.
  6. Fujimaki T, Matsutani M, Asai A, Kohno T, Koike M. Cerebral venous thrombosis due to high altitude polycythemia. J Neurosurg. 1986;64:148-1450.
  7. Zubieta-Castillo G, Zubieta-Callaja G, Arano E, Zubieta-alleja L. Respiratory disease, chronic mountain sickness and gender differences at high altitude. In: Ohno H, Kobayashi T, Masuyama S, Nakashima M, eds. Press Committee of the 3rd World Congress on Mountain Medicine and High Altitude Physiology, Matsumoto, Japan; 1998:132-137.
  8. Kryger M, McCullough R, Doekel R, et al. Excessive polycythemia of high altitude: role of ventilatory drive and lung disease. Am Rev Respir Dis. 1978;118(4):659-66.
  9. Villafuerte FC. New genetic and physiological factors for excessive erythrocytosis and Chronic Mountain Sickness. J Appl Physiol (1985). 2015;119(12):1481-1486. doi:10.1152/japplphysiol.00271.2015.
  10. Jiang C, Chen J, Liu F, et al. Chronic mountain sickness in Chinese Han males who migrated to the Qinghai-Tibetan plateau: application and evaluation of diagnostic criteria for chronic mountain sickness. BMC Public Health. 2014;14:701. doi:10.1186/1471-2458-14-701.
  11. Xie SW, Liu C, Gao YX, et al. The study of prevalence rate, and clinical characteristics of high altitude deterioration.Eur Rev Med Pharmacol Sci. 2015;19(18):3444-3449.
  12. Lorenzo FR, Huff C, Myllymäki M, et al. A genetic mechanism for Tibetan high-altitude adaptation. Nat Genet. 2014;46(9):951-956. doi:10.1038/ng.3067.
  13. Sahota IS, Panwar NS. Prevalence of chronic mountain sickness in high altitude districts of Himachal Pradesh. Indian J Occup Environ Med. 2013;17(3):94-100. doi:10.4103/0019-5278.130839.
  14. Li X, Pei T, Xu H, et al. Ecological study of community-level factors associated with chronic mountain sickness in the young male chinese immigrant population in Tibet. J Epidemiol. 2012;22(2):136-143. doi:10.2188/jea.JE20110058.
Volume 4, Issue 4 - Serial Number 15
Autumn 2016
Pages 132-134

  • Receive Date 03 August 2016
  • Revise Date 29 August 2016
  • Accept Date 06 September 2016